GlassScriptPhysician profile
Matthew Bridges
NPI 1134688286
$4,075.87
in general payments reported to CMS, 2019-2025
11 companies · $3,331 in 2025
The $3,331 reported for 2025 was more than what 94% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $745 · 2025: $3,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,080 · Food and Beverage: $1,897 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,079.62 |
| Food and Beverage | $1,897.26 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,722.45 | 2024-2025 | Inspire |
| Cochlear Americas | $407.60 | 2024-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Medtronic, INC. | $288.94 | 2024-2025 | Stealthstation S8 Platform, Propel |
| Glaxosmithkline, LLC. | $257.33 | 2025 | Nucala |
| Advanced Bionics, LLC | $112.86 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Genzyme Corporation | $88.03 | 2024-2025 | |
| Integra Lifesciences Corporation | $34.63 | 2024 | Microfrance, Codman Isocool Aht, Instruments-Orthopedic |
| Smith+Nephew, INC. | $31.79 | 2024 | Tula |
| Phathom Pharmaceuticals, INC. | $18.51 | 2024 | Voquezna |
| Stryker Corporation | $14.74 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.